Cetera Investment Advisers
PFE icon

Cetera Investment Advisers’s Pfizer PFE Stock Holding History

Cetera Investment Advisers’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,200
Closed -$12 – 4923
2025
Q4 		$12 Buy
+1,200
New +$30.3K ﹤0.01% 4681

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Cetera Investment Advisers's PFE Position: Q1 2026 in Review

Cetera Investment Advisers increased its Pfizer (PFE) stake by 2.1% in Q1 2026, buying an estimated $1.75M and bringing the position to 3,213,627 shares worth $90.2M. The position accounts for 0.1% of the portfolio, ranked #203.

Cetera Investment Advisers first reported a position in PFE in Q4 2015 and has held it in 42 quarters since. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Cetera Investment Advisers held 3,213,627 shares of Pfizer worth $90.2M as of Q1 2026.
  • Cetera Investment Advisers bought 65,634 Pfizer shares in Q1 2026, an estimated $1.75M.
  • Pfizer made up 0.1% of Cetera Investment Advisers's portfolio in Q1 2026, its #203 holding.
  • Cetera Investment Advisers first reported a position in Pfizer in Q4 2015 and has held it in 42 quarters since.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.